Century Therapeutics
IPSC
64 hedge funds and large institutions have $61M invested in Century Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
2% more funds holding
Funds holding: 63 → 64 (+1)
1.42% less ownership
Funds ownership: 33.8% → 32.38% (-1.4%)
12% less capital invested
Capital invested by funds: $69.5M → $61M (-$8.5M)
17% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$657K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$532K |
| 3 |
Morgan Stanley
New York
|
+$435K |
| 4 |
State Street
Boston,
Massachusetts
|
+$277K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.77M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$562K |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$507K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$449K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$383K |
IPSC Hedge Fund Activity: Q2 2023 in Review
64 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q2 2023, worth a combined $61M — down 12% from $69.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IPSC positions and 4 closed out — a net gain of 1 holder — while 20 added to existing stakes and 24 trimmed.
The largest buyer was BlackRock, adding an estimated $657K. The largest seller was Federated Hermes, cutting an estimated $1.77M.
- 64 institutional investors held Century Therapeutics (IPSC) as of Q2 2023, up from 63 in Q1 2023.
- Funds reported $61M of Century Therapeutics stock for Q2 2023, down 12% quarter-over-quarter.
- 5 funds opened new Century Therapeutics positions in Q2 2023 and 4 closed out, a net change of +1 holder.
- The largest Century Therapeutics buyer in Q2 2023 was BlackRock, an estimated $657K added.
- The largest Century Therapeutics seller in Q2 2023 was Federated Hermes, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2023.